Grade II Acute GVHD and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Posttransplant Cyclophosphamide

• Grade II acute GVHD improves progression-free survival after haplo BMT• Grade II acute GVHD decreases relapse after haplo BMT• Higher nucleated cell graft dose improves survival after haplo BMT• Higher nucleated cell graft dose decreases relapse and grade III-IV acute GVHD

Source: Biology of Blood and Marrow Transplantation - October 18, 2017 Category: Hematology Authors: Shannon R. McCurdy, Christopher G. Kanakry, Hua-Ling Tsai, Yvette L. Kasamon, Margaret M. Showel, Javier Bola ños-Meade, Carol Ann Huff, Ivan Borrello, William H. Matsui, Robert A. Brodsky, Richard F. Ambinder, Maria P. Bettinotti, Ephraim J. Fuchs, Gary Source Type: research